Skip to main content
Ajai Chari, MD, Oncology, New York, NY

AjaiChariMD

Oncology • New York, NY

Hematologic Oncology

Professor of Clinical Medicine, UCSF Director Multiple Myeloma Program

Request Appointment

Overview of Dr. Chari

Dr. Ajai Chari is an oncologist in New York, NY and is affiliated with UCSF Medical Center. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 18 years. Dr. Chari accepts several types of health insurance, listed below. He is one of 154 doctors at UCSF Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2002 - 2005
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • CA State Medical License
    CA State Medical License 2023 - 2025
  • NY State Medical License
    NY State Medical License 2000 - 2024

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Twice‐Weekly Ixazomib in Combination with Lenalidomide‐Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma  
    Myo Htut, Michaela Liedtke, Stephen D Smith, Craig C Hofmeister, Rachid Baz, Paul G Richardson, Cara A Rosenbaum, David H Vesole, Ajai Chari, Jesus G Berdeja, Noopur Raje, British Journal of Haematology

Abstracts/Posters

  • Ixazomib or Lenalidomide Maintenance Following Autologous Stem Cell Transplantation and Ixazomib, Lenalidomide, and Dexamethasone (IRD) Consolidation in Patients with ...
    Ajai Chari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
    Ajai Chari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...
    Ajai Chari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Subcutaneous Daratumumab Plus Standard Treatment Regimens in Patients with Multiple Myeloma across Lines of Therapy: Pleiades Study Update 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Minimal Residual Disease in Hematologic Malignancies: Testing Considerations and Challenges 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Authored Content

  • Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients with Relapsed or Refractory Multiple MyelomaJune 2016

Press Mentions

  • Studying the Promising Role of Bispecific Antibodies in Multiple Myeloma With Ajai Chari, MD
    Studying the Promising Role of Bispecific Antibodies in Multiple Myeloma With Ajai Chari, MDJanuary 31st, 2023
  • An Antibody Successfully Treats over 70% of Multiple Myeloma Patients in Trial
    An Antibody Successfully Treats over 70% of Multiple Myeloma Patients in TrialDecember 26th, 2022
  • New Cancer Drug Achieves 73% Response Rate in Patients
    New Cancer Drug Achieves 73% Response Rate in PatientsDecember 12th, 2022
  • Join now to see all

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Tennessee Network 5
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Carelink Health Plans PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Ajai Chari, Dr. Ajai Chari, MD, Dr. A Chari